latest news releases from the newsroom
Provalis plc Signs Vaccine Option Agreement with Aventis Pasteur
DEESIDE, Flintshire, U.K., Dec. 13, 2004 (PRIMEZONE) -- Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, today announces that it has signed an option agreement with Aventis Pasteur, the vaccines business of the sanofi-aventis Group, for the development of vaccine candidates to prevent streptococcus pneumoniae infection.
Unicorp Announces That it Has Secured a Drilling Contractor For the Cecilia Prospect Located in Hardin County Kentucky
HOUSTON, Dec. 10, 2004 (PRIMEZONE) -- Unicorp, Inc. (Pink Sheets:UCPI) announced today that it has secured a drilling contract with Reliford Drilling through its joint venture with P5 Petroleum for the Cecilia Prospect located in Hardin County, Kentucky. Drilling is expected to begin prior to the end of calendar 2004 and initial results of the test well are expected sometime in January. Pursuant to the agreement with P5 Petroleum, Unicorp is required to immediately fund an additional $480,000 upon P5 Petroleum executing this drilling contract.
Energy Conservation Technologies, Inc.
Energy Conservation Technologies, Inc. Initiates Commercialization of its HID Electronic Ballast
BOULDER, Colo., Dec. 10, 2004 (PRIMEZONE) -- Energy Conservation Technologies, Inc. (Pink Sheets:ENYC), landmark technology company ("Econ"), will be meeting with the National Mexican Power Authority (NMPA) and a well-established ballast manufacturer in Mexico City, Mexico, the week of December 13-17.
The Pomerantz Firm Charges Autobytel Inc. With Securities Fraud -- ABTL
NEW YORK, Dec. 10, 2004 (PRIMEZONE) -- Pomerantz Haudek Block Grossman & Gross LLP (www.pomerantzlaw.com) has filed a class action lawsuit in the United States District Court Central District of California, Southern Division, against Autobytel Inc. ("Autobytel" or the "Company") (Nasdaq:ABTL) and two of the Company's senior officers. The lawsuit is on behalf of all persons or entities who purchased the securities of the Company during the period between July 24, 2003 and October 21, 2004.
UTStarcom Investors May Seek Appointment as Lead Plaintiff -- UTSI
NEW YORK, Dec. 10, 2004 (PRIMEZONE) -- According to Pomerantz Haudek Block Grossman & Gross LLP (www.pomerantzlaw.com), which has filed a lawsuit against UTStarcom, Inc. ("UTStarcom" or the "Company") (Nasdaq:UTSI) and eight of the Company's senior executive officers and/or directors, on behalf of all persons or entities who purchased the securities of UTStarcom during the period from April 16, 2003 to September 20, 2004, inclusive (the "Class Period"), investors have until January 14, 2005 to seek appointment by the Court as one of the lead plaintiffs in the action.
Parker Waichman Alonso LLP
Parker & Waichman, LLP and Seeger Weiss LLP Retained by Family of Bextra User Who Died from Toxic Epidermal Necrolysis
NEW YORK, Dec. 10, 2004 (PRIMEZONE) -- Parker & Waichman, LLP and Seeger Weiss LLP have been retained by the family of an 83-year-old man who died as a result of Toxic Epidermal Necrolysis after using Bextra, a popular arthritis medication manufactured by Pfizer Inc. (NYSE:PFE). Toxic Epidermal Necrolysis or TENS is a life-threatening skin condition that causes severe rash, extensive skin peeling and sores on the mucous membranes. Recently, Pfizer Inc. added a black box warning on Bextra's label concerning Toxic Epidermal Necrolysis and Stevens Johnson Syndrome. For more information on side effects related to Bextra please visit www.bextralegalhelp.com or www.yourlawyer.com/practice/contact.htm?topic=Bextra .